#news #biotech Atea and Roche’s COVID-19 antiviral flunks phase 2, prompting switch that will delay pivotal data

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Atea and Roche’s COVID-19 antiviral flunks phase 2, prompting switch that will delay pivotal data .Atea and Roche’s COVID-19 antiviral flunks phase 2, prompting switch that will delay pivotal data
ntaylor
Tue, 10/19/2021 – 08:11

from FierceBiotech: Biotech https://ift.tt/3lUl10b